Skip to main content

STIFEL FINANCIAL CORP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 720672 ST. LOUIS, MO

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$71,916,158
+$2,802,789 QoQ
Shares Held
161,052
+5.6% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.41636241710752.ToString("F0")% Shared 0.0049673397412015995.ToString("F0")% None 2.5786702431512802.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $431,497,751 across 103 Biotechnology names. VRTX ranks #2 (16.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
161,052 $71,916,158

All Filings in VRTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $71,916,158 161,052
2025-12-31 $69,113,369 152,447
2025-09-30 $55,820,055 142,529
2025-06-30 $45,207,833 101,545
2025-03-31 $51,871,375 106,991
2024-12-31 $50,274,677 124,844
2024-09-30 $43,871,925 94,332
2024-06-30 $45,300,380 96,647
2024-03-31 $43,113,968 103,141
2023-12-31 $40,529,090 99,607
2023-09-30 $30,745,779 88,416
2023-06-30 $32,603,404 92,647
2023-03-31 $24,914,788 79,077
2022-12-31 $20,146,157 69,763
2022-09-30 $18,479,599 63,824
2022-06-30 $22,971,519 81,520
2022-03-31 $21,280,275 81,543
2021-12-31 $21,154,724 96,333
2021-09-30 $20,472,400 112,864
2021-06-30 $24,378,476 120,907
2021-03-31 $23,615,764 109,897
2020-12-31 $21,459,197 90,798
2020-09-30 $28,012,847 102,943
2020-06-30 $29,795,385 102,633
2020-03-31 $22,994,535 96,636